102 related articles for article (PubMed ID: 11179594)
1. Designing of an orally active complement C3a agonist peptide with anti-analgesic and anti-amnesic activity.
Jinsmaa Y; Takenaka Y; Yoshikawa M
Peptides; 2001 Jan; 22(1):25-32. PubMed ID: 11179594
[TBL] [Abstract][Full Text] [Related]
2. Anti-analgesic and anti-amnesic effect of complement C3a.
Jinsmaa Y; Takahashi M; Takahashi M; Yoshikawa M
Life Sci; 2000 Sep; 67(17):2137-43. PubMed ID: 11057763
[TBL] [Abstract][Full Text] [Related]
3. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
4. Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin.
Takahashi M; Moriguchi S; Ikeno M; Kono S; Ohata K; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
Peptides; 1996; 17(1):5-12. PubMed ID: 8822503
[TBL] [Abstract][Full Text] [Related]
5. Suppression of food intake by a complement C3a agonist [Trp5]-oryzatensin(5-9).
Ohinata K; Suetsugu K; Fujiwara Y; Yoshikawa M
Peptides; 2007 Mar; 28(3):602-6. PubMed ID: 17207895
[TBL] [Abstract][Full Text] [Related]
6. Enterostatin (VPDPR) has anti-analgesic and anti-amnesic activities.
Takenaka Y; Nakamura F; Jinsmaa Y; Lipkowski AW; Yoshikawa M
Biosci Biotechnol Biochem; 2001 Jan; 65(1):236-8. PubMed ID: 11272841
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of an orally available and long-acting analgesic peptide, N(alpha)-amidino-Tyr-D-Arg-Phe-MebetaAla-OH (ADAMB).
Ogawa T; Miyamae T; Murayama K; Okuyama K; Okayama T; Hagiwara M; Sakurada S; Morikawa T
J Med Chem; 2002 Nov; 45(23):5081-9. PubMed ID: 12408719
[TBL] [Abstract][Full Text] [Related]
8. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
Unson CG; Erickson BW; Hugli TE
Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
Gergen KA; Zadina JE; Paul D
Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
[TBL] [Abstract][Full Text] [Related]
10. The active site of C3a anaphylatoxin.
Caporale LH; Tippett PS; Erickson BW; Hugli TE
J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
[TBL] [Abstract][Full Text] [Related]
11. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
12. Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors.
Takahashi M; Moriguchi S; Suganuma H; Shiota A; Tani F; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
Peptides; 1997; 18(3):329-36. PubMed ID: 9145417
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of oryzatensin: a novel bioactive peptide with ileum-contracting and immunomodulating activities derived from rice albumin.
Takahashi M; Moriguchi S; Yoshikawa M; Sasaki R
Biochem Mol Biol Int; 1994 Aug; 33(6):1151-8. PubMed ID: 7804141
[TBL] [Abstract][Full Text] [Related]
14. Retro-nociceptin methylester, a peptide with analgesic and memory-enhancing activity.
Jinsmaa Y; Takahashi M; Fukunaga H; Yoshikawa M
Life Sci; 2000 Nov; 67(25):3095-101. PubMed ID: 11125846
[TBL] [Abstract][Full Text] [Related]
15. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
16. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
[TBL] [Abstract][Full Text] [Related]
17. Anti-amnesic effect of dimemorfan in mice.
Wang HH; Chien JW; Chou YC; Liao JF; Chen CF
Br J Pharmacol; 2003 Mar; 138(5):941-9. PubMed ID: 12642396
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide FF, pain and analgesia.
Roumy M; Zajac JM
Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
[TBL] [Abstract][Full Text] [Related]
20. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
Burger R; Zilow G; Bader A; Friedlein A; Naser W
J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
